0001104659-23-011714.txt : 20230207
0001104659-23-011714.hdr.sgml : 20230207
20230207160019
ACCESSION NUMBER: 0001104659-23-011714
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20230207
DATE AS OF CHANGE: 20230207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Butler Erin
CENTRAL INDEX KEY: 0001940413
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37544
FILM NUMBER: 23594986
MAIL ADDRESS:
STREET 1: 4375 LOMA RIVIERA COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Armata Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0000921114
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911549568
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4503 GLENCOE AVENUE
CITY: MARINA DEL REY
STATE: CA
ZIP: 90292
BUSINESS PHONE: 310-665-2928
MAIL ADDRESS:
STREET 1: 4503 GLENCOE AVENUE
CITY: MARINA DEL REY
STATE: CA
ZIP: 90292
FORMER COMPANY:
FORMER CONFORMED NAME: AmpliPhi Biosciences Corp
DATE OF NAME CHANGE: 20130222
FORMER COMPANY:
FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/
DATE OF NAME CHANGE: 19940331
3
1
tm235775-1_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2022-07-01
0
0000921114
Armata Pharmaceuticals, Inc.
ARMP
0001940413
Butler Erin
4503 GLENCOE AVENUE
MARINA DEL REY
CA
90292
0
1
0
0
Vice President,Finance & Admin
Stock Option (Right to Buy)
14.28
2027-09-17
Common Stock
714
D
Stock Option (Right to Buy)
3.15
2029-05-22
Common Stock
15000
D
Stock Option (Right to Buy)
5.14
2031-03-24
Common Stock
30000
D
Stock Option (Right to Buy)
5.11
2032-04-12
Common Stock
50000
D
Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Issuer's 2016 Equity Incentive Plan (the "2016 EIP"). All 714 stock options are fully vested and exercisable.
Reflects the grant of stock options to purchase shares of common stock of the Issuer under the 2016 EIP. 11,250 of the stock options are fully vested and exercisable. 3,750 of the stock options will vest on May 22, 2023.
Reflects the grant of stock options to purchase shares of common stock of the Issuer under the 2016 EIP. 7,500 of the stock options are fully vested and exercisable. 7,500 of the stock options will vest on March 25, 2023, 7,500 of the stock options will vest on March 25, 2024, and 7,500 of the stock options will vest on March 25, 2025.
Reflects the grant of stock options to purchase shares of common stock of the Issuer under the 2016 EIP. None of the stock options have fully vested and become exercisable. 12,500 of the stock options will vest on April 13, 2023, 12,500 of the stock options will vest on April 13, 2024, 12,500 of the stock options will vest on April 13, 2025, and 12,500 of the stock options will vest on April 13, 2026.
/s/ Erin Butler
2023-02-07